LivaNova PLC
LIVN
Clasificación en acciones
#3720
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
Precio por acción
$81.22
Capitalización bursátil
$4.46B
Cambio (1 día)
3.54%
Cambio (1 año)
48.07%
País
GB
Comercio LivaNova PLC (LIVN)
Categoría
Healthcare
Historial del precio de la acción de LivaNova PLC (LIVN)
Precio más alto de cierre: $77.04 el 2026-10-01
Precio más bajo de cierre: $65.54 el 2015-10-01
Precio más bajo de cierre: $65.54 el 2015-10-01
Historial del precio de la acción de LivaNova PLC desde 2015 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | 10.24% |
| 2025 | 28.07% |
| 2024 | 0.72% |
| 2023 | -10.64% |
| 2022 | -34.07% |
| 2021 | 32.23% |
| 2020 | -19.53% |
| 2019 | -16.15% |
| 2018 | 13.93% |
| 2017 | 79.34% |
| 2016 | -22.00% |
| 2015 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $102.65 | -19.77% |
US
|
|
| $96.45 | 0.57% |
IE
|
|
| $307.12 | -20.92% |
US
|
|
| $46.02 | -55.69% |
US
|
|
| $47.05 | -17.88% |
DE
|
